PRMT5 and B-cell chronic lymphocytic leukemia: When crossed with the Eμ-TCL1 model, double transgenic mice uniformly developed a highly aggressive disease with select focal lymphoid tumors transforming to histologically resemble RT, altogether proposing a direct cause-effect relationship for PRMT5 in the pathogenesis of RT and identifying an attractive therapeutic target for RT and CLL at risk of RT.